IL11 and colorectal carcinoma: In colitis-associated tumorigenesis and human CRC cohorts, heightened IL-11 signaling tracks with worse outcomes and promotes tumor cell survival by engaging STAT3—a pathway that drives target genes relevant to CRC biology, including SOCS3 and surviving.